Martha Mayo

Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors

Matthew R. Weir, George L. Bakris, David A. Bushinsky et al. · New England Journal of Medicine · 2014 · 658 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS

Peter S. Staats, Thomas Yearwood, Steven G. Charapata et al. · JAMA · 2004 · 644 citations

Nursing, Pharmacology, Pharmacotherapy +17

Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease

George L. Bakris, Bertram Pitt, Matthew R. Weir et al. · JAMA · 2015 · 437 citations

Medicine, Pharmacology, Pharmacotherapy +16

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

Rajiv Agarwal, Patrick Rossignol, Alain Romero et al. · The Lancet · 2019 · 362 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Mark S. Wallace, Steven G. Charapata, Robert B. Fisher et al. · Neuromodulation Technology at the Neural Interface · 2006 · 203 citations

Nursing, Pharmacotherapy, Pain Management +12